Clinical Trial Update: A Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the Lung [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating REOLYSIN in combination with paclitaxel and carboplatin for metastatic or recurrent squamous cell carcinoma of the lung has completed. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• REOLYSIN (pelareorep)

Snippet

Sponsor: Oncolytics Biotech | Conditions: Metastatic or Recurrent Squamous Cell Carcinoma of the Lung | Phase 2 | Status: COMPLETED